Valuation: Astal Laboratories Limited

Market Cap 2.76B 28.79M 24.94M 23.54M 21.36M 40.06M 40.35M 281M 108M 1.4B 108M 106M 4.45B P/E 2024
26.3x
P/E 2025 9.45x
Enterprise Value 2.87B 29.99M 25.99M 24.52M 22.25M 41.74M 42.04M 293M 113M 1.46B 113M 110M 4.64B EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
41.06%
Yield 2024 *
-
Yield 2025 -
1 day+0.53%
1 week-0.91%
Current month-5.19%
1 month-13.68%
3 months-1.40%
6 months+2.02%
Current year-12.26%
1 week 74.1
Extreme 74.1
79
1 month 62.8
Extreme 62.8
87.88
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 32.05
Extreme 32.05
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 15/07/2023
Compliance Officer 32 19/04/2023
Director TitleAgeSince
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.53%-0.91%-8.88%+137.75% 34.93M
+2.26%+1.53%+52.51%+92.87% 994B
+0.82%-0.59%+50.81%+63.39% 640B
+1.71%+5.13%+20.19%+70.24% 454B
+5.00%+2.21%+38.79%+39.24% 337B
+1.68%-9.20%+16.65%+24.87% 261B
+3.81%+0.93%+6.48%+12.39% 246B
+0.51%-3.56%+38.19%+44.56% 204B
+1.43%-6.21%-21.04%-58.94% 190B
+0.96%-1.04%+28.95%+87.59% 178B
Average +1.84%-5.27%+22.26%+51.40% 350.48B
Weighted average by Cap. +2.02%-4.42%+34.78%+57.39%

Financials

2024 2025
Net sales 237M 2.47M 2.14M 2.02M 1.83M 3.44M 3.46M 24.11M 9.29M 120M 9.27M 9.07M 382M 637M 6.64M 5.75M 5.43M 4.93M 9.24M 9.31M 64.86M 24.99M 323M 24.94M 24.39M 1.03B
Net income 7.85M 81.87K 70.94K 66.95K 60.74K 114K 115K 800K 308K 3.98M 307K 301K 12.66M 89.25M 931K 807K 761K 691K 1.3M 1.31M 9.09M 3.5M 45.28M 3.5M 3.42M 144M
Net Debt -57.64M -601K -521K -492K -446K -837K -843K -5.87M -2.26M -29.24M -2.26M -2.21M -92.97M 115M 1.2M 1.04M 984K 893K 1.68M 1.69M 11.76M 4.53M 58.53M 4.52M 4.42M 186M
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
11/09/26 INR 76.20 +0.53% 3,260
10/09/26 INR 75.80 -1.94% 6,371
09/09/26 INR 77.30 -1.58% 23,749
08/09/26 INR 78.54 +6.15% 5,344
07/09/26 INR 73.99 -3.78% 28,220
  1. Stock Market
  2. Stocks
  3. MACINTR Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!